News
MONT-SAINT-GUIBERT, Belgium, February 18, 2025--Regulatory News: Celyad Oncology (Euronext: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the "Company"), today announces the publication of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback